460 related articles for article (PubMed ID: 23364915)
1. Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death.
Hodge JW; Garnett CT; Farsaci B; Palena C; Tsang KY; Ferrone S; Gameiro SR
Int J Cancer; 2013 Aug; 133(3):624-36. PubMed ID: 23364915
[TBL] [Abstract][Full Text] [Related]
2. Docetaxel enhances CD3+ CD56+ cytokine-induced killer cells-mediated killing through inducing tumor cells phenotype modulation.
Wang W; Qin S; Zhao L
Biomed Pharmacother; 2015 Feb; 69():18-23. PubMed ID: 25661332
[TBL] [Abstract][Full Text] [Related]
3. Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing.
Gameiro SR; Jammeh ML; Wattenberg MM; Tsang KY; Ferrone S; Hodge JW
Oncotarget; 2014 Jan; 5(2):403-16. PubMed ID: 24480782
[TBL] [Abstract][Full Text] [Related]
4. Sublethal exposure to alpha radiation (223Ra dichloride) enhances various carcinomas' sensitivity to lysis by antigen-specific cytotoxic T lymphocytes through calreticulin-mediated immunogenic modulation.
Malamas AS; Gameiro SR; Knudson KM; Hodge JW
Oncotarget; 2016 Dec; 7(52):86937-86947. PubMed ID: 27893426
[TBL] [Abstract][Full Text] [Related]
5. RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8(+) T cells.
Duewell P; Steger A; Lohr H; Bourhis H; Hoelz H; Kirchleitner SV; Stieg MR; Grassmann S; Kobold S; Siveke JT; Endres S; Schnurr M
Cell Death Differ; 2014 Dec; 21(12):1825-37. PubMed ID: 25012502
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis.
Gelbard A; Garnett CT; Abrams SI; Patel V; Gutkind JS; Palena C; Tsang KY; Schlom J; Hodge JW
Clin Cancer Res; 2006 Mar; 12(6):1897-905. PubMed ID: 16551875
[TBL] [Abstract][Full Text] [Related]
7. Defining the molecular signature of chemotherapy-mediated lung tumor phenotype modulation and increased susceptibility to T-cell killing.
Gameiro SR; Caballero JA; Hodge JW
Cancer Biother Radiopharm; 2012 Feb; 27(1):23-35. PubMed ID: 22316209
[TBL] [Abstract][Full Text] [Related]
8. Apicidin and docetaxel combination treatment drives CTCFL expression and HMGB1 release acting as potential antitumor immune response inducers in metastatic breast cancer cells.
Buoncervello M; Borghi P; Romagnoli G; Spadaro F; Belardelli F; Toschi E; Gabriele L
Neoplasia; 2012 Sep; 14(9):855-67. PubMed ID: 23019417
[TBL] [Abstract][Full Text] [Related]
9. The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma.
He Z; Jing X; Dai X; Bao L; Yang X; Xiong Y; Li M
Front Biosci (Landmark Ed); 2024 Apr; 29(4):158. PubMed ID: 38682206
[TBL] [Abstract][Full Text] [Related]
10. Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing.
Gameiro SR; Malamas AS; Bernstein MB; Tsang KY; Vassantachart A; Sahoo N; Tailor R; Pidikiti R; Guha CP; Hahn SM; Krishnan S; Hodge JW
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):120-130. PubMed ID: 27084634
[TBL] [Abstract][Full Text] [Related]
11. The use of chelated radionuclide (samarium-153-ethylenediaminetetramethylenephosphonate) to modulate phenotype of tumor cells and enhance T cell-mediated killing.
Chakraborty M; Wansley EK; Carrasquillo JA; Yu S; Paik CH; Camphausen K; Becker MD; Goeckeler WF; Schlom J; Hodge JW
Clin Cancer Res; 2008 Jul; 14(13):4241-9. PubMed ID: 18594006
[TBL] [Abstract][Full Text] [Related]
12. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
Frost PJ; Butterfield LH; Dissette VB; Economou JS; Bonavida B
J Immunol; 2001 Mar; 166(5):3564-73. PubMed ID: 11207317
[TBL] [Abstract][Full Text] [Related]
13. Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes.
Garnett CT; Palena C; Chakraborty M; Tsang KY; Schlom J; Hodge JW
Cancer Res; 2004 Nov; 64(21):7985-94. PubMed ID: 15520206
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of three commercial photosensitizers for efficiency of inducing immunogenic cell death in anti-tumor immunotherapy].
Lin X; Mao D; Bai R
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1791-1798. PubMed ID: 36651246
[TBL] [Abstract][Full Text] [Related]
15. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
Uslu R; Borsellino N; Frost P; Gárban H; Ng CP; Mizutani Y; Belldegrun A; Bonavida B
Clin Cancer Res; 1997 Jun; 3(6):963-72. PubMed ID: 9815772
[TBL] [Abstract][Full Text] [Related]
16. Calreticulin acts as an adjuvant to promote dendritic cell maturation and enhances antigen-specific cytotoxic T lymphocyte responses against non-small cell lung cancer cells.
Liu X; Li J; Liu Y; Ding J; Tong Z; Liu Y; Zhou Y; Liu Y
Cell Immunol; 2016 Feb; 300():46-53. PubMed ID: 26702740
[TBL] [Abstract][Full Text] [Related]
17. Immunogenic cell death in anticancer chemotherapy and its impact on clinical studies.
Wang Q; Ju X; Wang J; Fan Y; Ren M; Zhang H
Cancer Lett; 2018 Dec; 438():17-23. PubMed ID: 30217563
[TBL] [Abstract][Full Text] [Related]
18. Cell death induced by cytotoxic CD8
Jaime-Sanchez P; Uranga-Murillo I; Aguilo N; Khouili SC; Arias MA; Sancho D; Pardo J
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32241808
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs.
Correale P; Del Vecchio MT; La Placa M; Montagnani F; Di Genova G; Savellini GG; Terrosi C; Mannucci S; Giorgi G; Francini G; Cusi MG
J Immunother; 2008; 31(2):132-47. PubMed ID: 18481383
[TBL] [Abstract][Full Text] [Related]
20. Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists.
Yamazaki T; Hannani D; Poirier-Colame V; Ladoire S; Locher C; Sistigu A; Prada N; Adjemian S; Catani JP; Freudenberg M; Galanos C; André F; Kroemer G; Zitvogel L
Cell Death Differ; 2014 Jan; 21(1):69-78. PubMed ID: 23811849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
